Conclusions
In conclusion, annexin A5 is a potent anticoagulant protein that forms an antithrombotic shield over anionic phospholipids containing bilayers. Autoantibodies may interfere with this shielding function via high affinity antibodies that recognize phospholipid binding proteins that are capable of interfering with the assembly of the annexin A5 shield on phospholipid surfaces or via direct recognition of annexin A5 functional epitopes by autoantibodies. Antibody mediated interference with the integrity of the two-dimensional annexin A5 crystal shield may be a mechanism for thrombosis and for pregnancy complications, including recurrent spontaneous pregnancy losses, in APS.
Keywords
- Annexin Versus
- Anionic Phospholipid
- Placental Villus
- Placental Trophoblast
- BeWo Cell Line
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Crumpton MJ, Dedman JR. Protein terminology tangle. Nature 1990;345:212.
Moss SE, Morgan RO. The annexins. Genome Biol 2004;5:219.
Mosser G, Ravanat C, Freyssinet JM, Brisson A. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol 1991;217:241–245.
Rand JH, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin a5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193–1200.
Voges D, Berendes R, Burger A, Demange P, Baumeister W, Huber R. Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study. J Mol Biol 1994;238:199–213.
Andree HAM, Stuart MC, Hermens WT, et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992;267:17907–17912.
van Heerde WL, Lap P, Schoormans S, de Groot PG, Reutelingsperger CPM, Vroom TM. Localization of annexin A5 in human tissues. Annexins 2004;1:56–62.
Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003;42:423–438.
van Eerden P, Wu XX, Chazotte C, Rand JH. The role of annexins in pregnancy. Annexins 2004;1:90–98.
Krikun G, Lockwood CJ, Wu XX, et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994;15:601–612.
Lyden TW, Vogt E, Ng AK, Johnson PM, Rote NS. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992;22:1–14.
Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999;180:1008–1016.
Rand JH, Wu XX, Andree HA, et al. Pregnancy loss in the antiphospholipid-antibody syndrome — a possible thrombogenic mechanism. N Engl J Med 1997;337:154–160.
Shu F, Sugimura M, Kanayama N, Kobayashi H, Kobayashi T, Terao T. Immunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest 2000;49:17–23.
Di Simone N, Castellani R, Caliandro D, Caruso A. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001;65:1766–1770.
Reutelingsperger CP, Kop JM, Hornstra G, Hemker HC. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J Biochem 1988;173:171–178.
Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990;115:174–181.
Rand JH, Wu XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566–1572.
Donohoe S, Kingdom JC, Mackie IJ, et al. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Thromb Haemost 2000;84:32–38.
La Rosa L, Meroni PL, Tincani A, et al. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684–1693.
Lakasing L, Campa JS, Poston R, Khamashta MA, Poston L. Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. Am J Obstet Gynecol 1999;181:180–189.
Rand JH, Wu XX, Guller S, et al. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997;177:918–923.
Rand JH, Wu XX, Andree HAM, et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a “lupus procoagulant” phenomenon. Blood 1998;92:1652–1660.
Vogt E, Ng AK, Rote NS. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997;177:964–972.
Hanly JG, Smith SA. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. J Rheumatol 2000;27:2152–2159.
Rand JH, Wu XX, Giesen P. A possible solution to the paradox of the “lupus anticoagulant”: antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V. Thromb Haemost 1999;82:1376–1377.
Rand JH, Wu XX, Giesen P, et al. Antiphospholipid antibodies reduce annexin-V and accelerate coagulation on cell membranes: mechanistic studies with a monoclonal antiphospholipid antibody. Thromb Haemost 1999;82(suppl):1531a.
Rand JH, Wu XX, Chen PP. Human monoclonal antiphospholipid antibodies displace annexin-V from phospholipid bilayers and accelerate thrombin generation. Blood 1999;94(suppl 1):623a.
Hanly JG, Smith SA. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol 2000;120:537–543.
Willems GM, Janssen MP, Comfurius P, Galli M, Zwaal RF, Bevers EM. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes. Biochemistry 2000;39:1982–1989.
Bevers EM, Janssen MP, Willems GM, Zwaal FA. No evidence for enhanced thrombin formation through displacement of annexin V by antiphospholipid antibodies. Thromb Haemost 2000;83:792–794.
Rand JH, Wu XX, Lapinski R, et al. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 2004. Epub ahead of print.
Tomer A. Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies. J Lab Clin Med 2002;139:147–154.
Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 2001;113:911–914.
Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001;76:694–699.
Gris JC, Perneger TV, Quere I, et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 2003;102:3504–3513.
Kristoffersen EK, Ulvestad E, Bjorge L, Aarli A, Matre R. Fc gamma-receptor activity of placental annexin II. Scand J Immunol 1994;40:237–242.
Nojima J, Kuratsune H, Suehisa E, et al. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001;47:1008–1015.
Siaka C, Lambert M, Caron C, et al. Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss. Rev Med Interne 1999;20:762–765.
Arai T, Matsubayashi H, Sugi T, et al. Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol 2003;50:202–208.
Lakos G, Kiss E, Regeczy N, et al. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol 2000;27:924–929.
Satoh A, Suzuki K, Takayama E, et al. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999;26:1715–1720.
Pasquier E, Amiral J, de Saint ML, Mottier D. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism. Thromb Haemost 2001;86:538–542.
Romisch J, Schuler E, Bastian B, et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis 1992;3:11–17.
Horlick KR, Ganjianpour M, Frost SC, Nick HS. Annexin-I regulation in response to suckling and rat mammary cell differentiation. Endocrinology 1991;128:1574–1579.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
Rand, J.H., Wu, XX. (2006). Annexins in Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_36
Download citation
DOI: https://doi.org/10.1007/1-84628-009-5_36
Publisher Name: Springer, London
Print ISBN: 978-1-85233-873-2
Online ISBN: 978-1-84628-009-2
eBook Packages: MedicineMedicine (R0)
